Cardiovascular effects of serotonin agonists and antagonists.
about
Studies on the antihypertensive and antidyslipidemic activities of Viola odorata leaves extractFurther characterization, by use of tryptamine and benzamide derivatives, of the putative 5-HT4 receptor mediating tachycardia in the pigFurther evidence that 5-HT-induced relaxation of pig pulmonary artery is mediated by endothelial 5-HT(2B) receptorsSerotonin: a different player in hypertension-associated thrombosisExploration of haplotype research consortium imputation for genome-wide association studies in 20,032 Generation Scotland participants.Sarpogrelate hydrochloride ameliorates diabetic nephropathy associated with inhibition of macrophage activity and inflammatory reaction in db/db mice.Bradycardia in serotonin-deficient Pet-1-/- mice: influence of respiratory dysfunction and hyperthermia over the first 2 postnatal weeksMolecular mechanisms of SERT in platelets: regulation of plasma serotonin levels.5-hydroxytryptamine (5-HT) reduces total peripheral resistance during chronic infusion: direct arterial mesenteric relaxation is not involved.Pharmacological profile of the 5-HT-induced inhibition of cardioaccelerator sympathetic outflow in pithed rats: correlation with 5-HT1 and putative 5-ht5A/5B receptors.The effect of acute tryptophan depletion on the neural correlates of emotional processing in healthy volunteers.Pharmacological profile of the receptors that mediate external carotid vasoconstriction by 5-HT in vagosympathectomized dogsThe 5-HT1-like receptor mediating the increase in canine external carotid blood flow: close resemblance to the 5-HT1D subtype.Inhibition of G protein-activated inwardly rectifying K+ channels by fluoxetine (Prozac).5-hydroxytryptamine has an endothelium-derived hyperpolarizing factor-like effect on coronary flow in isolated rat hearts.Sumatriptan-induced saphenous venoconstriction in the anaesthetized dog through 5-HT1-like receptor activationImportance of inositol (1,4,5)-trisphosphate, intracellular Ca2+ release and myofilament Ca2+ sensitization in 5-hydroxytryptamine-evoked contraction of rabbit mesenteric artery.Down-regulation of the serotonin transporter in hyperreactive platelets counteracts the pro-thrombotic effect of serotonin.Serotonin uptake rates in platelets from angiotensin II-induced hypertensive mice.Intraoperative pulseless ventricular tachycardia after Ondansetron.High affinity binding of epibatidine to serotonin type 3 receptorsCardiac arrest after tramadol injection in a polytrauma patientRabbit isolated renal artery contractions by some tryptamine derivatives, including 2-methyl-5-HT, are mediated by a 5-HT1-like receptor.5-Hydroxytryptamine receptors mediating vasoconstriction in pulmonary arteries from control and pulmonary hypertensive rats.The atypical 5-HT2 receptor mediating tachycardia in pithed rats: pharmacological correlation with the 5-HT2A receptor subtype.Role of 5-HT1-like receptors in the reduction of porcine cranial arteriovenous anastomotic shunting by sumatriptanMediation by 5-HT1D receptors of 5-hydroxytryptamine-induced contractions of rabbit middle and posterior cerebral arteries.Vascular 5-HT1-like receptors mediating vasoconstriction and vasodilatation: their characterization and distribution in the intact canine cardiovascular system.Analysis of the 5-HT receptors mediating contractions in the rabbit isolated renal artery.Inhibitory 5-hydroxytryptamine receptors involved in pressor effects obtained by stimulation of sympathetic outflow from spinal cord in pithed rats.Blockade of porcine carotid vascular response to sumatriptan by GR 127935, a selective 5-HT1D receptor antagonist.Differential effects of centrally-active antihypertensives on 5-HT1A receptors in rat dorso-lateral septum, rat hippocampus and guinea-pig hippocampus.Characterization of prejunctional 5-HT receptors mediating inhibition of sympathetic vasopressor responses in the pithed rat.Investigation of the role of 5-HT1B and 5-HT1D receptors in the sumatriptan-induced constriction of porcine carotid arteriovenous anastomoses.
P2860
Q21245692-D6B33816-457F-4B60-86CB-443EB516CDB8Q24673355-5705FF5F-9589-4073-86E6-F448A5AA4724Q24675027-1E97E9A8-1960-4845-9683-6FE6C2721332Q27022328-2D2E8092-2C7C-47F5-8621-017CF15AEE96Q30840891-F81DD735-ED2E-44B2-AE7B-6D53DC0C2F82Q33825220-787BEE66-A85E-4290-B41E-DF865B1770BCQ33841082-876DDB0E-B80B-49A6-B045-435A6B8BD740Q34248836-073365C3-DB3B-40A8-8246-A91CF5F5492AQ34258593-3C4EA0C5-DA17-45F6-AA5A-4492011BDF65Q34264341-20AC06D2-57A1-4BEE-A721-62932ABAE693Q34583146-493F52A3-3F94-47B9-9085-7DCE6D895263Q34732717-33EEE835-41B5-4F51-BFCF-1D83404A3723Q34792265-1B9D652F-7167-4B06-B82A-114EF4D8C637Q35045125-13093276-9404-4B48-9116-42F2D45BF974Q35741394-1F295E80-7C05-4E9F-AC6E-F40A603A076FQ35872845-791BC881-B0B0-407A-9F87-3C32DECEC61EQ35874247-A13DE937-4648-4C81-8119-77A51699B1B6Q35892630-C824AF92-795A-4C30-95EE-A60563510F69Q37250033-E7DFF30B-A71A-4E52-B813-4089715888E6Q39210790-B3FF8FC7-209F-490D-A314-DD67805D2A7BQ39646714-59681DBD-8BE0-49DF-930F-5414F3B58AD5Q39929053-5E46C210-1B82-4626-86E6-FCADE769152EQ41853498-47363262-47A3-4E8F-8979-25EDF093E818Q41883027-0D818F6E-9457-41EC-B809-20A10A1FEB65Q41916507-51EF3B35-4F73-42CB-98DF-27D4A03F1D55Q41970324-8DE91A8E-0F16-4E22-AEC4-B5B0C60EDF62Q42015479-2A516109-E169-4AF4-96D8-43EECFD48FB2Q42036074-14A37D36-7870-4182-A474-B888B15ACA0AQ42167283-B1923E1D-14F0-436E-8F6E-646ADDE67598Q42370812-CB791DC2-AE19-4C0D-A649-B99128E46DC9Q42682987-5DB307FA-26E3-4986-9265-81BDC9BCA83BQ42702463-24558A79-83DF-4810-81D0-8698A34DFE97Q42706955-CAA5BEBF-9FC7-4D1A-8E57-26D33503C2BAQ43192569-62DA2B34-E5C2-4AD1-9BE3-C341134E4337
P2860
Cardiovascular effects of serotonin agonists and antagonists.
description
1990 nî lūn-bûn
@nan
1990年の論文
@ja
1990年論文
@yue
1990年論文
@zh-hant
1990年論文
@zh-hk
1990年論文
@zh-mo
1990年論文
@zh-tw
1990年论文
@wuu
1990年论文
@zh
1990年论文
@zh-cn
name
Cardiovascular effects of serotonin agonists and antagonists.
@ast
Cardiovascular effects of serotonin agonists and antagonists.
@en
type
label
Cardiovascular effects of serotonin agonists and antagonists.
@ast
Cardiovascular effects of serotonin agonists and antagonists.
@en
prefLabel
Cardiovascular effects of serotonin agonists and antagonists.
@ast
Cardiovascular effects of serotonin agonists and antagonists.
@en
P1476
Cardiovascular effects of serotonin agonists and antagonists.
@en
P2093
Villalón CM
P304
P407
P478
15 Suppl 7
P577
1990-01-01T00:00:00Z